Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1Phase 1 1

Status

Recruiting 8Active not recruiting 6Not yet recruiting 5Completed 5Terminated 3Unknown 2Withdrawn 1Enrolling by invitation 1

Sponsor Class

OTHER 4NIH 1

Study Type

Interventional 3Observational 2

Sponsor

Cancer Type

Gastrointestinal 8Thoracic 5Gynecologic 4Lymphoid 3Head & Neck 3Endocrine 2Tumor-Agnostic 1Other hematologic neoplasm 1Myeloid 1Classical hematology 1

Conditions

Carcinoma, Non-Small-Cell Lung 4Lung Neoplasms 2Small Cell Lung Cancer Extensive Stage 1Pathologic Complete Response 1

Interventions

Carboplatin 58Cisplatin 39Drug Therapy 37Pemetrexed 36osimertinib 22anlotinib 22Etoposide 19tislelizumab 17Surgical Procedures, Operative 16Paclitaxel 16Radiotherapy 15toripalimab 14Docetaxel 14pembrolizumab 13130-nm albumin-bound paclitaxel 13Bevacizumab 12aflutinib 11sintilimab 10Specimen Handling 10durvalumab 9Magnetic Resonance Spectroscopy 9cemiplimab 8Platinum 8Injections 8Immunotherapy 8Platinum Compounds 7PM 01183 7Blood Specimen Collection 7ensartinib 6atezolizumab 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Not yet recruiting × Observation × Thoracic × Clear all
NCT07596524 2026-05-19

Analysis of Different Second Line Treatment in Advanced NSCLC Patients Progressing After 1st Line Immune Checkpoint Inhibitor Therapy

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Not yet recruiting
300 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT07388524 2026-05-13

Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial

National Cancer Institute (NCI)

Phase 3 Not yet recruiting
336 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT06743555 2026-04-28

SAVED LUNG

Centre hospitalier de l'Université de Montréal (CHUM)

Phase 1 Not yet recruiting
14 enrolled
Thoracic

Pathologic Complete Response, Carcinoma, Non-Small-Cell Lung

NCT07472478 2026-03-16

GIVEN

Guangdong Provincial People's Hospital

Phase 2 Not yet recruiting
32 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT05066945 2021-10-04

Application of ctDNA in the Evaluation of Curative Effect and Prognosis of SCLC Patients

Xiangya Hospital of Central South University

Not yet recruiting
40 enrolled
Thoracic

Small Cell Lung Cancer Extensive Stage

Data powered by HemOnc (CC BY 4.0) Colophon âš¡